Clinical Trial

Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease

Study acronym: TRICOLON
Recruiting
View on ClinicalTrials.gov →
Summary
TRICOLON is an investigator initiated, prospective, interventional, open-label, randomized, real-world, multi-centre, 3-arms study in the Netherlands. The primary objective is to investigate in COPD patients if single-inhaler triple therapy (SITT) is superior to multi-inhaler triple therapy (MITT) in terms of adherence to inhaled corticosteroids (ICS) therapy and to investigate if SITT with e-health support is superior to MITT and SITT without e-health support.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-08-08; most recent amendment 2025-08-20.
Status change: Not Yet Recruiting → Recruiting 2023-08-23
Trial Details
NCT Number NCT05495698
Lead Sponsor Franciscus Gasthuis
Conditions Copd, Adherence, Medication
Enrollment 300 participants
Start Date 2022-12-13
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-21